CLINICAL_TRIALS
trial_result
· 2026-03-12
Clinical Trial Update: Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients [Phase 1, Phase 2]
Summary
The Phase 1/2 clinical trial of AOC 1001 in adults with Myotonic Dystrophy Type 1 has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avidity Biosciences, Inc. | Conditions: DM1, Myotonic Dystrophy 1 | Phase 1, Phase 2 | Status: COMPLETED